Intra‐abdominal infectious complications within 30 days of surgery · people with inflammatory bowel disease
It is very uncertain whether risk of postoperative infectious complications: anti‐TNF agents changes intra‐abdominal infectious complications within 30 days of surgery compared with control (very low certainty).
1 finding from 1 review
Extra‐abdominal infections within 30 days of surgery · people with inflammatory bowel disease
It is very uncertain whether risk of postoperative infectious complications: anti‐TNF agents changes extra‐abdominal infections within 30 days of surgery compared with control (very low certainty).
1 finding from 1 review
Infectious complications · people with inflammatory bowel disease
It is very uncertain whether risk of postoperative infectious complications: anti‐integrin agents changes overall infectious complications within 30 days of surgery compared with control (very low certainty).
3 findings from 1 review
OR 1.11 [0.76, 1.62]
9 studies · 9 participants
Very low
OR 1.04 [0.79, 1.36]
2 studies · 2 participants
Low
OR 1.06 [0.54, 2.1]
7 studies · 7 participants
Very low
Incisional infections and wound dehiscence within 30 days of surgery · people with inflammatory bowel disease
It is very uncertain whether risk of postoperative infectious complications: anti‐integrin agents changes incisional infections and wound dehiscence within 30 days of surgery compared with control (very low certainty).
1 finding from 1 review
Intra‐abdominal infectious complications within 30 days of surgery · people with inflammatory bowel disease
It is very uncertain whether risk of postoperative infectious complications: anti‐integrin agents changes intra‐abdominal infectious complications within 30 days of surgery compared with control (very low certainty).
1 finding from 1 review
Extra‐abdominal infections within 30 days of surgery · people with inflammatory bowel disease
It is very uncertain whether risk of postoperative infectious complications: anti‐integrin agents changes extra‐abdominal infections within 30 days of surgery compared with control (very low certainty).
1 finding from 1 review
Incisional infections and wound dehiscence within 30 days of surgery · people with inflammatory bowel disease
It is very uncertain whether risk of postoperative infectious complications: corticosteroids changes incisional infections and wound dehiscence within 30 days of surgery compared with control (very low certainty).
1 finding from 1 review
Intra‐abdominal infectious complications within 30 days of surgery · people with inflammatory bowel disease
It is very uncertain whether risk of postoperative infectious complications: corticosteroids changes intra‐abdominal infectious complications within 30 days of surgery compared with control (very low certainty).
1 finding from 1 review
Extra‐abdominal infections within 30 days of surgery · people with inflammatory bowel disease
It is very uncertain whether risk of postoperative infectious complications: corticosteroids changes extra‐abdominal infections within 30 days of surgery compared with control (very low certainty).
1 finding from 1 review
Infectious complications · people with inflammatory bowel disease
It is very uncertain whether risk of postoperative infectious complications: 5‐ASA changes overall infectious complications within 30 days of surgery compared with control (very low certainty).
3 findings from 1 review
OR 0.76 [0.51, 1.14]
6 studies · 6 participants
Very low
no estimate extracted
0 studies · 0 participants
GRADE not reported
OR 0.76 [0.51, 1.14]
6 studies · 6 participants
Very low
Mastectomy skin flap necrosis (number of women with mastectomy skin flap necrosis within 30 days after surgery) · women undergoing immediate breast reconstruction following mastectomy
It is very uncertain whether indocyanine Green Angiography (ICGA) changes mastectomy skin flap necrosis (number of women with mastectomy skin… compared with clinical evaluation (very low certainty).
1 finding from 1 review
Infection (number of breasts with infection within 30 days after surgery) · women undergoing immediate breast reconstruction following mastectomy
It is very uncertain whether indocyanine Green Angiography (ICGA) changes infection (number of breasts with infection within 30 days after… compared with clinical evaluation (very low certainty).
1 finding from 1 review
RR 0.65 [0.44, 0.97]
Studies not reported
Very low
Haematoma (number of breasts with haematoma within 30 days after surgery) · women undergoing immediate breast reconstruction following mastectomy
It is very uncertain whether indocyanine Green Angiography (ICGA) changes haematoma (number of breasts with haematoma within 30 days after… compared with clinical evaluation (very low certainty).
1 finding from 1 review
RR 1.53 [0.47, 4.95]
Studies not reported
Very low
Seroma (30 days) · women undergoing immediate breast reconstruction following mastectomy
It is very uncertain whether indocyanine Green Angiography (ICGA) changes seroma (number of breast with seroma within 30 days after surgery) compared with clinical evaluation (very low certainty).
2 findings from 1 review
Reoperation · women undergoing immediate breast reconstruction following mastectomy
It is very uncertain whether indocyanine Green Angiography (ICGA) changes reoperation (number of women that were operated again within 30 days… compared with clinical evaluation (very low certainty).
2 findings from 1 review
Dehiscence · women undergoing immediate breast reconstruction following mastectomy
It is very uncertain whether indocyanine Green Angiography (ICGA) changes dehiscence (number of women with dehiscence within 30 days after… compared with clinical evaluation (very low certainty).
1 finding from 1 review
Infection (number of women with infection of the skin flap or implant within 30 days after surgery) · women undergoing immediate breast reconstruction following mastectomy
It is very uncertain whether indocyanine Green Angiography (ICGA) changes infection (number of women with infection of the skin flap or… compared with clinical evaluation (very low certainty).
1 finding from 1 review
Haematoma (proportion of participants in each group with haematoma; · women undergoing immediate breast reconstruction following mastectomy
It is very uncertain whether indocyanine Green Angiography (ICGA) changes haematoma (number of women with haematoma within 30 days after… compared with clinical evaluation (very low certainty).
1 finding from 1 review
Mastectomy skin flap necrosis (number of breasts with mastectomy skin flap necrosis within 30 days after surgery) · women undergoing immediate breast reconstruction following mastectomy
It is very uncertain whether indocyanine Green Angiography (ICGA) changes mastectomy skin flap necrosis (number of breasts with mastectomy… compared with clinical evaluation (very low certainty).
1 finding from 1 review
RR 0.62 [0.48, 0.82]
Studies not reported
Very low
Urinary continence 3 months after surgery MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
Retzius‐sparing RALP may leads to higher urinary continence 3 months after surgery MCID: 5% absolute difference compared with standard RALP (low certainty).
1 finding from 1 review